Www.ias2013.org Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Access to HCV triple therapy with Telaprevir or Boceprevir in a real-life setting in HIV-HCV.
Edited by Morris Sherman MD BCh PhD FRCP(C) Associate Professor of Medicine
Simone Strasser Stephen Pianko Adverse events and drug interactions.
